AzTrials
AzTrials

Temporomandibular Joint DysfunctionMRITMJNCT02294799

Magnetic Ressonance Imaging of Temporomandibular Joint

A study testing Intervention Group in people with Temporomandibular Joint Dysfunction, run by Daniela Ap. Biasotto-Gonzalez at 1 site in Brazil.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Background: Among the instrumental devices that have been proposed over the years to integrate the clinical evaluation of temporomandibular joint disorders (TMD), imaging techniques are the most studied, showing that magnetic resonance imaging (MRI) is the technique most need to describe the anatomy of the TMJ and to… Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Temporomandibular Joint Dysfunction
What is being tested?
Intervention Group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteBrazil
Study dates
Aug 2026to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • TMD diagnosed subjects by RDC / TMD confirmed by the MRI findings,
  • with anterior disk displacement with or without reduction,
  • with full dentition (excluding third molars).

Who cannot join

  • Subjects diagnosed TMD exclusively muscular;
  • with posterior and / or medial displacement of the disc;
  • showing systemic diseases that affect the joints and / or masticatory muscles;
  • neuromuscular diseases;
  • hypo / condylar hyperplasia;
  • making use of any type of dental prosthesis;
Show all 9Show fewer
  • are in orthodontic and / or physical therapy;
  • showing neurological or behavioral disorders that preclude the achievement of MRI and/or
  • a history of previous TMJ surgery.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

DANIELA AP BIASOTTO-GONZALEZ, PHD contact

+55 11 36659325

dani_atm@ig.com.br

Brazil1 site
  • University of Nove de Julho

    São Paulo, São Paulo, 01415000

Other trials in Brazil

About this study

Official title: Magnetic Ressonance Imaging Evaluation of Articular Disc Position in TMD Subjects After Mandibular Mobilization. A Double Blind, Randomized, Placebo-controlled Study

Background: Among the instrumental devices that have been proposed over the years to integrate the clinical evaluation of temporomandibular joint disorders (TMD), imaging techniques are the most studied, showing that magnetic resonance imaging (MRI) is the technique most need to describe the anatomy of the TMJ and to evaluate the correlation of imaging findings with the clinical diagnosis . Despite the amount available studies on the use of MRI for evaluation of TMJ disorders and treatments, there is a lack of studies that evaluate the imaging findings after physical therapy. Purpose: To evaluate the influence of nonspecific mandibular mobilization about the positioning of the articular disc by MRI in individuals with TMD diagnosis of anterior disc displacement with and without reduction according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Analyze the behavior of pain through the numerical scale of pain assessment (END) at baseline and after each treatment session, the quality of life of individuals with TMD at baseline, immediately, three and six months after the treatment sessions by the World Health Organization Quality of Life Assessment (WHOQOL - BREF), and The Patient's Specific Functional Scale (PSFS) at baseline and after treatment. The treatment will be performed three times a week during four weeks. Metodology: This is a randomized, placebo controlled, blind study designed to assess the effects of techniques nonspecific mandibular mobilization x placebo. Individuals will be randomized and divided into two groups: Group A (intervention) and Group B (placebo). Statistic analysis: The positioning of the articular disc, extracted through the use of MRI, will be considered the primary outcome and, as a secondary outcome will be assessed the quality of life, pain and function after treatment. The adherence of the data to a Gaussian curve will be verified by the Shapiro-Wilk and the data are expressed as mean values and standard deviation. Two-way repeated measures analysis of variance with Bonferroni post hoc test will be used for inter-and intra-group comparisons. The significance level is adjusted p ≤ 0.05.

Read the detailed description

This is a randomized, placebo-controlled, double-blind study designed to verify the effects of nonspecific mandibular mobilization techniques x placebo

Being tested
Intervention Group, Placebo group
Keywords
Temporomandibular Joint Disorders, Magnetic Ressonance Imaging, Complementary Therapy, Physical Therapy Modalities.
Medical subject headings
Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention GroupOther

    Also called Mandibular Mobilization

    Grade 1, Nonspecific Mandibular Mobilization

  • Placebo groupOther

    Also called Placebo Mandibular Mobilization

    Nonspecific Mandibular Movement.

Study groups in NCT02294799
Study groupRoleWhat they receive
Intervention GroupOtherTMD diagnosed sujects that will receive the mobilization treatment
Receives: Other: Intervention Group
Placebo GroupPlacebo comparatorTMD diagnosed sujects that will receive the placebo treatment
Receives: Other: Placebo group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Articular Disc Positioning (Measured by the Magnetic Ressonance Imaging)

    Measured by the Magnetic Ressonance Imaging

    Measured: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

Secondary outcomes (3)
  1. Clinical Symptoms (Measured by END)

    Measured by numerical scale of pain assessment (END)

    Measured: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

  2. Functionality (Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012)

    Mesuread by "The Patient´s Specific Funcional Scale - HORN, 2012

    Measured: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.

  3. Quality of life (Whoqol-bref)

    Whoqol-bref

    Measured: Baseline (day 1) and after 4 weeks of treatment (performed 3 times a week), 3 and 6 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2014 (estimated)
  2. Study startAug 2026 (estimated)
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02294799
Sponsor's protocol ID
YEH1984
Acronym
MRITMJ
Status last verified
Feb 2025
First submitted
9 Apr 2013
Last updated
28 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ahmad M, Hollender L, Anderson Q, Kartha K, Ohrbach R, Truelove EL, John MT, Schiffman EL. Research diagnostic criteria for temporomandibular disorders (RDC/TMD): development of image analysis criteria and examiner reliability for image analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jun;107(6):844-60. doi: 10.1016/j.tripleo.2009.02.023.

    PubMed 19464658
  • de Lucena LB, Kosminsky M, da Costa LJ, de Goes PS. Validation of the Portuguese version of the RDC/TMD Axis II questionnaire. Braz Oral Res. 2006 Oct-Dec;20(4):312-7. doi: 10.1590/s1806-83242006000400006.

    PubMed 17242791
  • Gray RJ, Quayle AA, Hall CA, Schofield MA. Physiotherapy in the treatment of temporomandibular joint disorders: a comparative study of four treatment methods. Br Dent J. 1994 Apr 9;176(7):257-61. doi: 10.1038/sj.bdj.4808429.

    PubMed 8186034
  • Furto ES, Cleland JA, Whitman JM, Olson KA. Manual physical therapy interventions and exercise for patients with temporomandibular disorders. Cranio. 2006 Oct;24(4):283-91. doi: 10.1179/crn.2006.044.

    PubMed 17086858
  • Ohnuki T, Fukuda M, Nakata A, Nagai H, Takahashi T, Sasano T, Miyamoto Y. Evaluation of the position, mobility, and morphology of the disc by MRI before and after four different treatments for temporomandibular joint disorders. Dentomaxillofac Radiol. 2006 Mar;35(2):103-9. doi: 10.1259/dmfr/25020275.

    PubMed 16549437
  • Horn KK, Jennings S, Richardson G, Vliet DV, Hefford C, Abbott JH. The patient-specific functional scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012 Jan;42(1):30-42. doi: 10.2519/jospt.2012.3727. Epub 2011 Oct 25.

    PubMed 22031594
  • Aigner M, Forster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol. 2006 Jan;41(1):81-6. doi: 10.1007/s00127-005-0997-8. Epub 2006 Jan 1.

    PubMed 16341612
  • El Hage Y, Politti F, de Sousa DF, Herpich CM, Gloria IP, Gomes CA, Amaral AP, de Melo NC, da Silva TC, Arruda EE, Amorim CF, Gadotti IC, Gonzalez TO, Berzin F, Bussadori SK, Garcia MB, Barbosa BR, Biasotto-Gonzalez DA. Effect of mandibular mobilization on electromyographic signals in muscles of mastication and static balance in individuals with temporomandibular disorder: study protocol for a randomized controlled trial. Trials. 2013 Oct 1;14:316. doi: 10.1186/1745-6215-14-316.

    PubMed 24083628
  • Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011 Oct;152(10):2399-2404. doi: 10.1016/j.pain.2011.07.005.

    PubMed 21856077
  • Emshoff R, Brandlmaier I, Gerhard S, Strobl H, Bertram S, Rudisch A. Magnetic resonance imaging predictors of temporomandibular joint pain. J Am Dent Assoc. 2003 Jun;134(6):705-14. doi: 10.14219/jada.archive.2003.0256.

    PubMed 12839406
  • Emara AS, Faramawey MI, Hassaan MA, Hakam MM. Botulinum toxin injection for management of temporomandibular joint clicking. Int J Oral Maxillofac Surg. 2013 Jun;42(6):759-64. doi: 10.1016/j.ijom.2013.02.009. Epub 2013 Mar 26.

    PubMed 23538215

Questions about this trial

What is this clinical trial studying?

A study testing Intervention Group in people with Temporomandibular Joint Dysfunction, run by Daniela Ap. Biasotto-Gonzalez at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact DANIELA AP BIASOTTO-GONZALEZ, PHD (+55 11 36659325, dani_atm@ig.com.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Articular Disc Positioning (Measured by the Magnetic Ressonance Imaging) (time frame: Baseline (day 1) and after 4 weeks of treatment performed 3 times a week.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02294799, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in